Precision BioSciences Inc.
DTIL | NASDAQ
$6.50
-$0.17 (-2.55%)
At close: Sep 21, 2026, 4:00 PM ET
$6.50
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $83.38M
Enterprise Value $-2.56M
Beta 1.25
Average Volume 377.61K
Shares Outstanding (Diluted) 25.86M
Shares Change YoY 134.07%
Institutional Ownership 65.56%
Exchange NASDAQ
ISIN US74019P2074
Price Performance
Price Change 1M -26.3%
Price Change 3M -6.5%
Price Change 6M 0.5%
Price Change YTD 58.5%
Price Change 1Y 33.7%
Price Change 3Y -43.0%
Price Change 5Y -98.3%
1M CAGR (ann.) -13.2%
1Y CAGR (ann.) 32.4%
5Y CAGR (ann.) -55.7%
All-Time CAGR -44.3%
Valuation
PE Ratio -2.32
Forward PE N/A
PEG Ratio -0.02
Forward PEG 0.11
PS Ratio 1.85
Forward PS 9.40
PB Ratio 1.84
P/FCF Ratio -1.30
P/Adj. FCF Ratio -1.14
P/OCF Ratio -3.23
EV/Sales -0.06
EV/EBIT 0.05
EV/EBITDA 0.05
EV/FCF 0.04
Earnings Yield -43.1%
FCF Yield -76.6%
Adj. FCF Yield -87.9%
Financial Health
Net Cash $85.94M
Total Debt $1.61M
Cash & Short-Term Investments $87.55M
Total Assets $125.92M
Current Ratio 12.82
Quick Ratio 12.82
Debt / Equity Ratio 0.62
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -39.70
Interest Coverage -27.55
Altman Z-Score -6.03
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -80.8%
EBITDA Margin -111.1%
Net Profit Margin -117.0%
FCF Margin -141.8%
Adj. FCF Margin -162.6%
SBC / Revenue 17.4%
SBC Impact (per share) -14.7%
Returns
Return on Assets -41.9%
Return on Equity -91.6%
Return on Invested Capital -30.2%
Return on Capital Employed -30.6%
Return on Tangible Assets -42.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -1.1%
Revenue CAGR 5Y -15.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -45.0%
EPS CAGR 5Y 61.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y 1.5%
FCF CAGR 5Y 9.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 8.7%
Revenue Growth Next 3Y -20.2%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) -$0.85
EPS Growth Est (next Q) -53.8%
Revenue Est (next Q) $1.38M
Revenue Growth Est (next Q) 10476.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20
Price Target Upside 207.7%
Cash Flow
Operating Cash Flow $-63.84M
Free Cash Flow $-63.91M
Adj. Free Cash Flow $-73.28M
FCF Per Share -$2.01
OCF Per Share -$2.01
OCF/S Ratio -115.2%
Income Statement
Revenue $45.06M
Gross Profit $45.06M
Operating Income $-36.4M
EBITDA $-50.05M
Net Income $-52.73M
EPS (Diluted) -$2.80
Revenue / Employee $672.46K
Profit / Employee $-787.04K
Employees 67
Add to Watchlist
Select watchlists to add or remove DTIL